Friday, June 1, 2018, at 15:45 Novartis has announced that the European Medicines Agency (EMA) Committee on Human Use Medicines (CHMP) has recommended Aimovig (erenumab) approval to prevent migraine in adults suffering at least 4 days of migraine per month. The World Health Organization (WHO) has mentioned migraine as one of the top ten causes […]
Novartis’ Migraine prevention therapy is closer to being approved Read More »
Recurrent, troublesome occipital pain associated with muscular tension is known as Arnold’s neuralgia, a strange condition. The condition of peripheral nerves can produce the pain of varying intensity as a reflex mechanism, depending on the degree of damage being considered. Some anatomical locations are often associated with these syndromes, with the exception of the occipital
Arnold Neuralgia/Recurrent occipital pain cause Read More »
The year 2017 marks the 50th anniversary for spinal cord stimulation therapy which was first used to treat pain in 1967. To celebrate the occasion, NeuroNews spoke to a number of pioneers in the field about how they have seen spinal cord stimulation therapy change and develop over the years and where they hope to see it
Marking 50 years of spinal cord stimulation Read More »
Don't miss out on any updates! Join our community and discover
the latest research, treatments, and events on migraine.
Subscribe now!
